CD Capital
Finance · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Room 1168 W Nanjing Rd 3906, 200041, Chi...Website
www.cd-healthinv.comRevenue
$13.2 MillionIndustry
About CD Capital
CD Capital Org Chart
Is CD Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if CD Capital is spiking on competitors!
Check if CD Capital has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on CD Capital recently announced quarterly report
Product Launch: Get notified when CD Capital launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if CD Capital had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once CD Capital has new funding data
CD Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at CD Capital
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
CD Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
CD Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about CD Capital.
CD Capital Tech Stack
A closer look at the technologies used by CD Capital
Top Finance Companies
Frequently Asked Questions Regarding CD Capital
CD Capital is a Shanghai-based venture capital firm specializing in transformative investments in medical devices and life sciences. Established in 2013, the firm has managed over $1.4 billion and has supported more than 90 entrepreneurs and innovative companies in the MedTech sector. With a focus on excellence and credibility, CD Capital aims to h... Read More